Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 1
2008 2
2009 2
2010 1
2012 1
2013 3
2014 1
2015 1
2016 3
2017 6
2018 3
2019 2
2020 15
2021 13
2022 10
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry Analysis.
Yogeswaran A, Gall H, Fünderich M, Wilkins MR, Howard L, Kiely DG, Lawrie A, Hassoun PM, Sirenklo Y, Torbas O, Sweatt AJ, Zamanian RT, Williams PG, Frauendorf M, Arvanitaki A, Giannakoulas G, Saleh K, Sabbour H, Cajigas HR, Frantz R, Al Ghouleh I, Chan SY, Brittain E, Annis JS, Pepe A, Ghio S, Orfanos S, Anthi A, Majeed RW, Wilhelm J, Ghofrani HA, Richter MJ, Grimminger F, Sahay S, Tello K, Seeger W; Pulmonary Vascular Research Institute GoDeep Consortium. Yogeswaran A, et al. Among authors: sahay s. Chest. 2024 Mar 19:S0012-3692(24)00309-X. doi: 10.1016/j.chest.2024.03.018. Online ahead of print. Chest. 2024. PMID: 38508334 Free article.
Rebuttal From Dr Sahay.
Sahay S. Sahay S. Chest. 2024 Mar;165(3):498-499. doi: 10.1016/j.chest.2023.07.4230. Chest. 2024. PMID: 38461014 No abstract available.
Chronic Thromboembolic Pulmonary Hypertension.
Estrada RA, Auger WR, Sahay S. Estrada RA, et al. Among authors: sahay s. JAMA. 2024 Mar 19;331(11):972-973. doi: 10.1001/jama.2023.24265. JAMA. 2024. PMID: 38407914
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group.
Morland K, Gerges C, Elwing J, Visovatti SH, Weatherald J, Gillmeyer KR, Sahay S, Mathai SC, Boucly A, Williams PG, Harikrishnan S, Minty EP, Hobohm L, Jose A, Badagliacca R, Lau EMT, Jing ZC, Vanderpool RR, Fauvel C, Leonidas Alves J Jr, Strange G, Pulido T, Qian J, Li M, Mercurio V, Zelt JGE, Moles VM, Cirulis MM, Nikkho SM, Benza RL, Elliott CG. Morland K, et al. Among authors: sahay s. Pulm Circ. 2023 Dec 21;13(4):e12317. doi: 10.1002/pul2.12317. eCollection 2023 Oct. Pulm Circ. 2023. PMID: 38144948 Free PMC article.
Tyvaso DPI: Drug-device characteristics and patient clinical considerations.
McEvoy C, Argula R, Sahay S, Shapiro S, Eagan C, Hickey AJ, Smutney C, Dillon C, Winkler T, Davis BN, Broderick M, Burger C. McEvoy C, et al. Among authors: sahay s. Pulm Pharmacol Ther. 2023 Dec;83:102266. doi: 10.1016/j.pupt.2023.102266. Epub 2023 Nov 13. Pulm Pharmacol Ther. 2023. PMID: 37967762 Free article. Review.
78 results